Benjamin Fryer

Benjamin Fryer has a diverse work experience spanning over two decades. Benjamin began their career as a PhD student at the University of Pennsylvania School of Medicine in 1998 and completed their studies in 2004. Following this, they worked as a Post-Doctoral Fellow at the University of Pennsylvania from 2005 to 2006. Benjamin then joined Janssen, Pharmaceutical Companies of Johnson and Johnson as a Research Scientist from 2006 to 2014. In 2015, they joined the University of Washington as a Team Leader, CMC, Cardiomyocyte Cell Manufacturing, a role they held until 2018. Finally, in 2018, they co-founded Pluristyx, Inc. and served as the CEO.

Benjamin Fryer obtained a B.A. in History from Colorado College, although the start and end years were not specified. Benjamin later pursued a PhD in Pharmacology from the University of Pennsylvania, which they completed between 1998 and 2004. In 2011, Benjamin received an Executive Certificate in Management and Leadership from the MIT Sloan School of Management.